0001048477-24-000073.txt : 20240506 0001048477-24-000073.hdr.sgml : 20240506 20240506164049 ACCESSION NUMBER: 0001048477-24-000073 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240502 FILED AS OF DATE: 20240506 DATE AS OF CHANGE: 20240506 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ajer Jeffrey Robert CENTRAL INDEX KEY: 0001557533 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26727 FILM NUMBER: 24918206 MAIL ADDRESS: STREET 1: C/O BIOMARIN PHARMACEUTICAL INC. STREET 2: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC CENTRAL INDEX KEY: 0001048477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 680397820 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 4155066700 MAIL ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 4 1 wk-form4_1715028037.xml FORM 4 X0508 4 2024-05-02 0 0001048477 BIOMARIN PHARMACEUTICAL INC BMRN 0001557533 Ajer Jeffrey Robert C/O BIOMARIN PHARMACEUTICAL INC. 770 LINDARO STREET SAN RAFAEL CA 94901 0 1 0 0 EVP, Chief Commercial Officer 1 Common Stock 2024-04-30 5 A 0 E 300 68.646 A 71767 D Common Stock 2024-05-02 4 S 0 5000 82.91 D 66767 D Represents the shares acquired by the reporting person on April 30, 2024, pursuant to the issuer's Employee Stock Purchase Plan. Trade made pursuant to a 10b5-1 plan executed on April 13, 2023. /s/ Tae Sang Yoo, Attorney-in-Fact 2024-05-06